Literature DB >> 10774995

Multisystem involvement in congenital insensitivity to pain with anhidrosis (CIPA), a nerve growth factor receptor(Trk A)-related disorder.

E Toscano1, R della Casa, S Mardy, L Gaetaniello, F Sadile, Y Indo, C Pignata, G Andria.   

Abstract

Congenital insensitivity to pain with anhidrosis (CIPA), a rare autosomal recessive disorder, is characterized by insensitivity to pain, self-mutilating behaviour, anhidrosis and recurrent hyperpyrexia. It is a hereditary sensory and autonomic neuropathy, also classified as HSAN, due to a defect of the receptor for nerve growth factor. CIPA is the first human genetic disorder caused by a defect in the neurotrophin signal transduction system. This is the first clinical report of CIPA patients characterized on molecular grounds. The clinical phenotypes of our patients show that CIPA is characterized by a multisystem involvement besides the nervous system, including bone fracture with slow healing, immunologic abnormalities, such as low response to specific stimuli, chronic inflammatory state ending in systemic amyloidosis. The molecular characterization allows a better understanding of most of the clinical features.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10774995     DOI: 10.1055/s-2000-15296

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  11 in total

1.  Congenital insensitivity of pain with anhidrosis.

Authors:  Bhaskar Gupta
Journal:  Indian J Pediatr       Date:  2003-01       Impact factor: 1.967

2.  NGF-TrkA signaling in sensory nerves is required for skeletal adaptation to mechanical loads in mice.

Authors:  Ryan E Tomlinson; Zhi Li; Zhu Li; Liliana Minichiello; Ryan C Riddle; Arun Venkatesan; Thomas L Clemens
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-17       Impact factor: 11.205

Review 3.  Impact of the Autonomic Nervous System on the Skeleton.

Authors:  Florent Elefteriou
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

4.  Fracture repair requires TrkA signaling by skeletal sensory nerves.

Authors:  Zhu Li; Carolyn A Meyers; Leslie Chang; Seungyong Lee; Zhi Li; Ryan Tomlinson; Ahmet Hoke; Thomas L Clemens; Aaron W James
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

5.  NGF-TrkA Signaling by Sensory Nerves Coordinates the Vascularization and Ossification of Developing Endochondral Bone.

Authors:  Ryan E Tomlinson; Zhi Li; Qian Zhang; Brian C Goh; Zhu Li; Daniel L J Thorek; Labchan Rajbhandari; Thomas M Brushart; Liliana Minichiello; Fengquan Zhou; Arun Venkatesan; Thomas L Clemens
Journal:  Cell Rep       Date:  2016-08-25       Impact factor: 9.423

6.  A novel lymphocyte signaling defect: trk A mutation in the syndrome of congenital insensitivity to pain and anhidrosis (CIPA).

Authors:  I Melamed; J Levy; R Parvari; E W Gelfand
Journal:  J Clin Immunol       Date:  2004-07       Impact factor: 8.317

7.  Cardiac arrest after anesthetic management in a patient with hereditary sensory autonomic neuropathy type IV.

Authors:  Yakup Ergül; Bariş Ekici; Sabiha Keskin
Journal:  Saudi J Anaesth       Date:  2011-01

Review 8.  From murine to human nude/SCID: the thymus, T-cell development and the missing link.

Authors:  Rosa Romano; Loredana Palamaro; Anna Fusco; Leucio Iannace; Stefano Maio; Ilaria Vigliano; Giuliana Giardino; Claudio Pignata
Journal:  Clin Dev Immunol       Date:  2012-03-05

9.  Identification of a novel nonsense mutation of the neurotrophic tyrosine kinase receptor type 1 gene in two siblings with congenital insensitivity to pain with anhidrosis.

Authors:  Ting Wang; Haibo Li; Jingjing Xiang; Bin Wei; Qin Zhang; Qin Zhu; Minjuan Liu; Miao Sun; Hong Li
Journal:  J Int Med Res       Date:  2017-03-27       Impact factor: 1.671

10.  Innervation is higher above Bone Remodeling Surfaces and in Cortical Pores in Human Bone: Lessons from patients with primary hyperparathyroidism.

Authors:  Manasi Sayilekshmy; Rie Bager Hansen; Jean-Marie Delaissé; Lars Rolighed; Thomas Levin Andersen; Anne-Marie Heegaard
Journal:  Sci Rep       Date:  2019-03-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.